Drug intelligence / Profile preview

emulgel

Development stage
Preclinical
Lead developer
Instituto de Investigación Biotecnológica, Farmacéutica y Medicamentos Huérfanos
Modality
Hydrogel Systems → Drug Delivery Systems, Classical Binding Small Molecules → Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Hormones & Growth Factors → Recombinant Proteins and Enzymes
Administration
Topical
01

Overview

Emulgel is a topical formulation designed for the concomitant treatment of atopic dermatitis (AD). It combines the properties of emulsions and gels, offering easy spreadability, emollience, and enhanced skin penetration. The formulation contains a blend of active ingredients including hyaluronic acid, glycerol, Calendula officinalis extract, Aloe vera extract, polyphenols from grape seed oil, and epidermal growth factor (EGF). This combination aims to improve skin barrier function, reduce inflammation, promote hydration, and support skin repair, thereby alleviating symptoms of AD. The EGF component is stabilized using a patented method to ensure its efficacy within the emulsion.

02

Targets

IgE (Immunoglobulin E)IL-4 (Interleukin 4)EGFR (Epidermal growth factor receptor)

Beyond the preview

Go deeper on emulgel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on emulgel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call